| Literature DB >> 32772887 |
Rahime Eshaghi Malekshah1, Bahareh Fahimirad1, Mohammadreza Aallaei2, Ali Khaleghian3.
Abstract
Superparamagnetic iron oxide nanoparticles have been syntheEntities:
Keywords: MTT assay; Synthesis; computational methods; molecular docking; nanocarrier
Year: 2020 PMID: 32772887 PMCID: PMC7470030 DOI: 10.1080/10717544.2020.1801890
Source DB: PubMed Journal: Drug Deliv ISSN: 1071-7544 Impact factor: 6.419
Scheme 1.The synthesize of Fe3O4@SiO2@APTS NPs functionalized by ∼ NH2-Schiff and its Cu(II).
Figure 1.FTIR spectra of bare (a) Fe3O4 MNPs; (b) Fe3O4@SiO2; (c) Fe3O4 MNPs treated by APTES; (d) Fe3O4 MNPs coated by Schiff base; (e) Fe3O4@SiO2@APTS ∼ Schiff base-Cu(II).
Figure 3.The anti-growth effect after the treatment with varying doses of Fe3O4@SiO2@APTS (A); Fe3O4@SiO2@APTS ∼ Schiff base (B); APTS ∼ Schiff base-Cu(II) (C) on K562 cell lines by the MTT. Data were normalized as a percentage of values of the control (*p<.05 and **p<.01).
Figure 2.EDX spectra obtained for Fe3O4@SiO2@APTS ∼ Schiff base-Cu(II) nanoparticles.
CSP results showing list of unique crystal structures ranked on the basis of the calculated lattice energy and density.
| Compound | Fe3O4 | Fe3O4@SiO2 | Fe3O4@SiO2@APTS | Fe3O4@SiO2@APTS ∼ Schiff base | Fe3O4@SiO2@APTS ∼ Schiff base-Cu(II) |
|---|---|---|---|---|---|
| Crystal system | Rhombohedral | Rhombohedral | Rhombohedral | Rhombohedral | Rhombohedral |
| Space group | |||||
| 6.034 | 9.025 | 8.466 | 9.771 | 9.973 | |
| 6.034 | 9.025 | 8.466 | 9.771 | 9.973 | |
| 6.034 | 9.025 | 8.466 | 9.771 | 9.973 | |
| 60.00 | 90.000 | 90.000 | 90.000 | 90.000 | |
| 60.00 | 90.000 | 90.000 | 90.000 | 90.000 | |
| 60.00 | 90.000 | 90.000 | 90.000 | 90.000 | |
| Cell volume | – | 735.092 | 606.957 | 933.148 | 992.22 |
| Final energy | –8688.084 eV | –11752.099 | –12044.134 eV | –16508.423 eV | –18154.089 eV |
DNA docking results of the compounds (unit: kcal/mol).
| Structures | Estimated free energy of binding | Final intermolecular energy (kcal/mol) | vdW + Hbond + desolv energy (kcal/mol) | Electrostatic energy (kcal/mol) | Final total internal energy (kcal/mol) | Torsional free energy (kcal/mol) | Unbound system's energy (kcal/mol) |
|---|---|---|---|---|---|---|---|
| Mitoxantrone | –10.35 | –15.07 | –11.84 | –3.23 | –4.48 | +4.77 | –4.48 |
| Trifluridine | –5.56 | –6.93 | –6.85 | –0.09 | –0.82 | +1.37 | –0.82 |
| Fe3O4@SiO2 | –6.46 | –12.42 | –12.25 | –0.17 | –3.29 | +5.97 | –3.29 |
| Fe3O4@SiO2@APTS | –10.85 | –11.20 | –10.39 | –5.67 | –1.58 | +5.21 | –1.58 |
| Fe3O4@SiO2@APTS ∼ Schiff base | –7.47 | –14.60 | –13.30 | –1.30 | –4.68 | +7.13 | –4.68 |
| Fe3O4@SiO2@APTS ∼ Schiff base-Cu(II) | –7.59 | –8.69 | –8.45 | –0.24 | –0.13 | +1.10 | –0.13 |
*ΔGbinding = ΔGvdW + hb+desolv + ΔGelec + ΔGtotal + ΔGtor − Δgunb
Topoisomerase II docking results of the compounds (unit: kcal/mol).
| Structures | Estimated free energy of binding | Final intermolecular energy (kcal/mol) | vdW + Hbond + desolv energy (kcal/mol) | Electrostatic energy (kcal/mol) | Final total internal energy (kcal/mol) | Torsional free energy (kcal/mol) | Unbound system's energy (kcal/mol) |
|---|---|---|---|---|---|---|---|
| Doxorubicin | –6.94 | –10.22 | –8.37 | +1.85 | –4.88 | +3.28 | –4.88 |
| Fe3O4@SiO2 | –3.69 | –9.65 | –9.61 | +0.05 | –1.72 | +5.97 | –1.72 |
| Fe3O4@SiO2@APTS | –7.70 | –14.03 | –7.52 | –6.51 | –2.45 | +6.26 | –2.45 |
| Fe3O4@SiO2@APTS ∼ Schiff base | –3.52 | –10.68 | –7.78 | –2.9 | –5.82 | +7.16 | –5.82 |
| Fe3O4@SiO2@APTS ∼ Schiff base-Cu(II) | –7.94 | –11.22 | –9.09 | –2.13 | –2.06 | +3.28 | –2.06 |
*ΔGbinding = ΔGvdW + hb+desolv + ΔGelec + ΔGtotal + ΔGtor − Δgunb
Figure 7.Docking conformation and interactions of all synthesized compounds with anionic membrane POPC.
Ribonucleotide reductase docking results of compounds (unit: kcal/mol).
| Structures | Estimated free energy of binding | Final intermolecular energy (kcal/mol) | vdW + Hbond + desolv energy (kcal/mol) | Electrostatic energy (kcal/mol) | Final total internal energy (kcal/mol) | Torsional free energy (kcal/mol) | Unbound system's energy (kcal/mol) |
|---|---|---|---|---|---|---|---|
| Triapine | –3.03 | –4.52 | –4.45 | –0.07 | –0.89 | +1.49 | –0.89 |
| Fe3O4@SiO2 | –2.13 | –8.10 | –8.00 | –0.10 | –3.04 | +5.97 | –3.04 |
| Fe3O4@SiO2@APTS | –8.45 | –14.12 | –8.06 | –6.06 | –1.37 | +5.67 | –1.37 |
| Fe3O4@SiO2@APTS ∼ Schiff base | –5.22 | –2.24 | –1.81 | –0.43 | –14.22 | +7.46 | –14.22 |
| Fe3O4@SiO2@APTS ∼ Schiff base-Cu(II) | –7.21 | –8.40 | –8.38 | –0.02 | –0.11 | +1.19 | –0.11 |
*ΔGbinding = ΔGvdW + hb+desolv + ΔGelec + ΔGtotal + ΔGtor − Δgunb
Lipid docking results of compounds (unit: kcal/mol).
| Structures | Estimated free energy of binding | Final intermolecular energy (kcal/mol) | vdW + Hbond + desolv energy (kcal/mol) | Electrostatic energy (kcal/mol) | Final total internal energy (kcal/mol) | Torsional free energy (kcal/mol) | Unbound system's energy (kcal/mol) |
|---|---|---|---|---|---|---|---|
| Fe3O4@SiO2 | –1.66 | –7.62 | –7.62 | –0.01 | –3.17 | +5.97 | –3.17 |
| Fe3O4@SiO2@APTS | –3.31 | –9.87 | –8.64 | –1.24 | –4.04 | +6.56 | –4.04 |
| Fe3O4@SiO2@APTS ∼ Schiff base | –0.57 | –10.11 | –10.09 | –0.02 | –7.25 | +9.55 | –7.25 |
| Fe3O4@SiO2@APTS ∼ Schiff base-Cu(II) | –5.30 | –9.18 | –8.81 | –0.37 | –1.82 | +3.88 | –1.82 |
*ΔGbinding = ΔGvdW + hb+desolv + ΔGelec + ΔGtotal + ΔGtor − Δgunb